Figure 1
![Figure 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-9-55/MediaObjects/12885_2008_Article_1389_Fig1_HTML.jpg)
Ad-IFNγ concentrations in the tumor, heart, liver, spleen, lung, kidney, brain, and blood at different time points after intratumoral injection of Ad-IFNγ. The dose of injection was 1 × 1010 VP/tumor. Data represent mean ± SD of three mice. Representative results from two independent experiments are shown.